Authors (including presenting author) :
Chan SC(1), Wong CW(1), Chan YK(1), Chan T(1), Chow MF(1)
Affiliation :
(1)Department of Medicine & Geriatrics, Pok Oi Hospital
Introduction :
AF is one of the contributing factors of ischemic stroke, oral anticoagulation is recommended for stroke prevention. AF predicts worse prognosis in patients with DM. Diabetic neuropathy may also mask the cardiac symptoms of AF and made them more prone for silent onset of AF. AF screening is not routinely done in clinical practice, but it is worth to do for stroke prevention. Various hand-held smartphone based ECG monitor device is available and gaining popularity in performing AF screening, which is time and cost effective compare with performing a standard 12-lead ECG.
Objectives :
1.Access the effectiveness of AF screening program using AliveCor 2.Screen for silent/unknown AF and consider start anticoagulation for stroke prevention
Methodology :
Patients aged 65 or above, without history of known AF or implanted cardiac devices are selected to perform a single lead ECG by using AliveCor, a smartphone based cardiac monitoring system, performed and screened by cardiac nurse. When the ECG is undetermined or suspected AF, a standard 12-lead ECG will be performed by SOPD staff. The 12-lead ECG will be assessed by the attending doctor, once AF is confirmed, doctor will refer the patient to warfarin clinic for consideration to start anticoagulant for the prevention of stroke.
Result & Outcome :
Total 115 DM patients were screened, 5 of them were screened with undetermined ECG from AliveCor, a further 12-lead ECG was done and interpreted. Nobody was found to have AF from this screening project.
Co-location with:
